--- title: "5 Stock Picks Last Week From Wall Street's Most Accurate Analysts" type: "News" locale: "en" url: "https://longbridge.com/en/news/304846480.md" description: "Benzinga highlights stock picks from five highly accurate Wall Street analysts. Harlan Sur (JP Morgan) maintains an Overweight on Microchip Technology with a $100 target. Nick McKay (Freedom Capital Markets) keeps a Buy on DraftKings, lowering the target to $25. Blayne Curtis (Jefferies) holds a Buy on Nova Ltd., cutting the target to $460. Sergey Pigarev (Freedom Broker) retains a Hold on ExxonMobil, raising the target to $162. David Risinger (Leerink Partners) downgrades Halozyme Therapeutics to Market Perform but raises the target to $117." datetime: "2026-11-09T11:25:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/304846480.md) - [en](https://longbridge.com/en/news/304846480.md) - [zh-HK](https://longbridge.com/zh-HK/news/304846480.md) generator: "portal-rs" --- # 5 Stock Picks Last Week From Wall Street's Most Accurate Analysts U.S. stocks settled mixed on Friday, with the Nasdaq Composite gaining over 1% after recording sharp losses in the previous session. Major averages recorded losses last week, with the Nasdaq losing 3.4% and the S&P 500 falling 2.7%. The 30-stock Dow, meanwhile, lost 0.9% during the week. Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst’s opinion to trust. Benzinga’s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market. **Top Analyst Picks:** Fortunately, any Benzinga reader can access the latest analyst ratings on the Analyst Stock Ratings page. One of the ways traders can sort through Benzinga’s extensive database of analyst ratings is by analyst accuracy. Here’s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga Analyst Stock Ratings. **Analyst**: Harlan Sur - **Analyst Firm**: JP Morgan - **Ratings Accuracy**: 83% - **Latest Rating**: Maintained an Overweight rating on **Microchip Technology Incorporated** (NASDAQ:MCHP) and cut the price target from $120 to $100 on Nov. 6. This analyst sees around 71% upside in the stock. - **Recent News:** On Nov. 5, Microchip Technology reported upbeat second-quarter financial results and issued third-quarter guidance with its midpoint below estimates. **Analyst**: Nick McKay - **Analyst Firm**: Freedom Capital Markets - **Ratings Accuracy**: 82% - **Latest Rating**: Maintained a Buy rating on **DraftKings Inc.** (NASDAQ:DKNG) and cut the price target from $28.5 to $25 on Nov. 6. This analyst sees around 35% upside in the stock. - **Recent News**: On Nov. 5, DraftKings reported worse-than-expected quarterly financial results and cut its FY26 sales guidance below estimates. **Analyst:** Blayne Curtis - **Analyst Firm:** Jefferies - **Ratings Accuracy:** 79% - **Latest Rating:** Maintained a Buy rating on **Nova Ltd.** (NASDAQ:NVMI) and cut the price target from $600 to $460 on Nov. 6. This analyst sees around 47% gain in the stock. - **Recent News:** On Nov. 5, Nova posted upbeat quarterly earnings. **Analyst:** Sergey Pigarev - **Analyst Firm:** Freedom Broker - **Ratings Accuracy:** 78% - **Latest Rating:** Maintained a Hold rating on **ExxonMobil Holdings Corporation** (NYSE:XOM) and raised the price target from $142 to $162 on Nov. 6. This analyst expects around 3% decline in the stock. - **Recent News:** On Oct. 30, ExxonMobil reported better-than-expected third-quarter earnings and revenue. **Analyst:** David Risinger - **Analyst Firm:** Leerink Partners - **Ratings Accuracy:** 77% - **Latest Rating:** Downgraded rating on **Halozyme Therapeutics, Inc.** (NASDAQ:HALO) from Outperform to Market Perform and raised the price target from $110 to $117 on Nov. 6. This analyst sees around 13% jump in the stock. - **Recent News:** On Nov. 5, Halozyme Therapeutics posted upbeat quarterly earnings. *Photo via Shutterstock* ### Related Stocks - [DKNG.US](https://longbridge.com/en/quote/DKNG.US.md) - [HALO.US](https://longbridge.com/en/quote/HALO.US.md) - [MCHP.US](https://longbridge.com/en/quote/MCHP.US.md) - [NVMI.US](https://longbridge.com/en/quote/NVMI.US.md) - [XOM.US](https://longbridge.com/en/quote/XOM.US.md) - [DKNX.US](https://longbridge.com/en/quote/DKNX.US.md) - [DKUP.US](https://longbridge.com/en/quote/DKUP.US.md) - [DRAY.US](https://longbridge.com/en/quote/DRAY.US.md) - [MCHG.US](https://longbridge.com/en/quote/MCHG.US.md) - [MCHU.US](https://longbridge.com/en/quote/MCHU.US.md) - [XOMO.US](https://longbridge.com/en/quote/XOMO.US.md) - [XOMX.US](https://longbridge.com/en/quote/XOMX.US.md) - [XOMZ.US](https://longbridge.com/en/quote/XOMZ.US.md) ## Related News & Research - [Earnings Beat Could Change The Case For Halozyme Stock](https://longbridge.com/en/news/304632165.md) - [Microchip forecasts Q3 adjusted gross margin below estimates](https://longbridge.com/en/news/304527874.md) - [DraftKings Analysts Slash Their Forecasts After Downbeat Q3 Results](https://longbridge.com/en/news/304848483.md) - [DraftKings Stock After Guidance Cut Has The Bull Case Changed](https://longbridge.com/en/news/304774032.md) - [Microchip Technology Incorporated $MCHP Stake Increased by Rakuten Investment Management Inc.](https://longbridge.com/en/news/304435981.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**